Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIG1 | P18858 | 1/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.57 |
| ▸ | HPGD | P15428 | 1/20 | 0.57 |
| ▸ | HCRTR1 | O43613 | 2/20 | 0.56 |
| ▸ | MCHR1 | Q99705 | 5/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.47 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.47 |
| ▸ | ACHE | P22303 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Alloclamide SCHEMBL872157 | 0.84 | MCHR1 (0.53) | ALDH1A1KDM4EHPGDMCHR1SMN1; SMN2 | |
| Alloclamide SCHEMBL29730070 | 0.84 | MCHR1 (0.53) | ALDH1A1KDM4EHPGDMCHR1SMN1; SMN2 | |
| Alloclamide SCHEMBL209095 | 0.83 | MCHR1 (0.52) | ALDH1A1KDM4EHPGDMCHR1SMN1; SMN2 | |
| Alloclamide SCHEMBL27527103 | 0.82 | MCHR1 (0.51) | ALDH1A1KDM4EHPGDMCHR1SMN1; SMN2 | |
| Flualamide SCHEMBL2734613 | 0.81 | MCHR1 (0.58) | ALDH1A1MCHR1TSHRLMNASLC22A2 | |
| Flualamide SCHEMBL29804765 | 0.81 | MCHR1 (0.58) | ALDH1A1MCHR1TSHRLMNASLC22A2 | |
| SCHEMBL11783506 | 0.81 | KDM4E (0.57) | ALDH1A1KDM4EHPGDHCRTR1MCHR1 | |
| SCHEMBL11619021 | 0.80 | LMNA (0.47) | ALDH1A1KDM4EHPGDMCHR1SMN1; SMN2 | |
| SCHEMBL10656342 | 0.77 | ADRA2A (0.49) | ALDH1A1KDM4EHPGDMCHR1SMN1; SMN2 | |
| SCHEMBL28696012 | 0.76 | LIG1 (0.77) | LIG1ALDH1A1KDM4EHPGDHCRTR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050260238-A1 | Cosmetic compositions comprising wholly hydrophilic block copolymers and particular anti-fungal agents | L'OREAL (FR) | 2005-11-24 | — | — | US | disclosed |
| EP-1595525-A1 | Composition containing a combination of a block copolymer exclusively based on hydrophile blocks and a particular antifungicide | L'OREAL (FR) | 2005-11-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050260238-A1 | Cosmetic compositions comprising wholly hydrophilic block copolymers and particular anti-fungal agents | SCLY, SUCLG1, POLR1C | LIG1 1594/4885ALDH1A1 1032/4885KDM4E 1764/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.